State Street To Present At Goldman Sachs US Financial Services Conference; Webcast At 9:20 AM ET

United Airlines, Archer To Launch First Air Taxi Route In Chicago

Aunt Millie's Our Family White Hot Dog Buns Recalled

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

FDA Clears Eat Just's Good Meat Cultivated Chicken

Attorneys General Of 23 US States Urge Hyundai, Kia To Take Swift Action Against Car Thefts

Kagome Worcester, Chuno, Take Out Tonkatsu Sauces Recalled

Domino's Offering 50% Off Menu-Priced Pizzas Through March 26

FDA Bans 2 Vuse Solo Menthol E-cigarette Products

Foot Locker Q4 Profit Down, Warns On FY23; To Close Hong Kong Operations

Hoyo, SBC Recalls Frozen, Ready-To-Eat Beef Sambusa Product

Mockingbird Expands Recall To Include Single Strollers

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

Accenture Sees Higher Q3 Revenues; Cuts FY23 Earnings, Sales Growth View - Update

FDA Clears Eat Just's Good Meat Cultivated Chicken

Pearson In Deal To Sell Pearson Online Learning Services To Regent

Foot Locker Q4 Profit Down, Warns On FY23; To Close Hong Kong Operations

Zai Lab Partner Karuna's Phase 3 Trial Of KarXT In Schizophrenia Meets Primary Endpoint

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

PDD Holdings Q4 Profit Rises 43%

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

Sandoz Gets FDA Approval For Biosimilar Hyrimoz High-concentration Formulation

89bio: Phase 2b ENLIVEN Trial Of Pegozafermin In Patients With NASH Meets Primary Goals

Illumina: Icahn's Director Nominees Do Not Add Value To Board

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

Playtech FY22 Profit Down, Revenues Rise; Says Strong Start To FY23

Biogen Updates On FDA Advisory Committee Meeting On Tofersen For SOD1-ALS

ITT Ink 10-Year Strategic Agreement With Continental To Supply Aftermarket Brake Pads

Heidelberg Materials Lifts Annual Dividend

Kite Reports Primary Overall Survival Analysis Results Of Phase 3 ZUMA-7 Study

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

Coya Therapeutics In Deal With Dr. Reddy's To License Proposed Biosimilar Abatacept For Coya 302

Canadian Solar Inc. Q4 Income Rises

Trupanion CFO Drew Wolff To Step Down Effective June 1

HORNBACH Group FY Adj. EBIT To Decrease By Approx. 20%; Group Sales Up 6.6%

Accenture Sees Higher Q3 Revenues; Cuts FY23 Earnings, Sales Growth View - Update